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Neuromuscular electrical stimulation appears to be useful 
in people with severe chronic obstructive pulmonary disease
Synopsis
Summary of: Vivodtzev I et al (2012) Functional and 
muscular effects of neuromuscular electrical stimulation 
in patients with severe COPD: a randomised clinical trial. 
Chest 141: 716–725. [Prepared by Kylie Hill, CAP Editor.]
Question: In patients with chronic obstructive pulmonary 
disease (COPD), what effect does neuromuscular electrical 
stimulation (NMES) have on muscle function and walking 
endurance? Design: Randomised, controlled trial in which 
the patients and those who collected outcome measures 
were blinded to group allocation. Setting: Home-based 
intervention with outcomes collected at a hospital in 
Quebec City, Canada. Participants: Patients who were 
clinically stable, sedentary and able to travel to the hospital 
with: (a) a smoking history > 20 pack-years, (b) severe 
airﬂow obstruction, and (c) a 6-minute walk distance 
< 400 m. Exclusion criteria comprised any co-morbid 
condition associated with muscle wasting. Randomisation 
of 22 patients allocated 13 to the intervention group and 9 
to the control group. Interventions: Both groups received 
electrical stimulation 5 times a week for 6 weeks. Each 
session comprised 35 min of bilateral stimulation for the 
quadriceps and 25 min of bilateral stimulation for the calf. 
Stimulation was applied with the patient in sitting. They 
were encouraged to increase the intensity to the maximum 
they could tolerate. Patients were visited weekly at home by 
a research nurse to monitor progress. Parameters used by 
the intervention group were 50 Hz frequency, 400 μs pulse 
duration, and 6 sec/16 sec duty cycle. Parameters used by 
the control/sham group were 5 Hz frequency, 100 μs pulse 
duration, applied continuously. Outcome measures: The 
primary outcome was quadriceps strength. The secondary 
outcomes included quadriceps endurance and performance 
during the endurance shuttle walk test. Results: Data 
were available on 12 and 8 patients in the intervention and 
control groups, respectively. Current intensity increased 
over the training period in the intervention group from 20 ± 
4 mA to 31 ± 10 mA (p < 0.001). Compared with the control 
group, the intervention group conferred greater gains in 
quadriceps force (difference in mean percent change from 
baseline 14%, 95% CI 1% to 26%) and endurance (42%, 95% 
CI 4% to 80%), but not walking endurance. Conclusion: 
In patients with severe COPD, NMES delivered at home 
enhanced muscle function but not walking endurance.
[95% CIs provided by primary author on request]
Commentary
Neuromuscular electrical stimulation (NMES) has 
increasingly been used in patients with chronic heart 
failure and chronic obstructive pulmonary disease with 
or without volitional exercise (Sillen et al 2009) and more 
recently in critically ill patients (Gerovasili et al 2009a). 
This well-designed, randomised study addressed some of 
the issues raised by the heterogeneity of NMES protocols 
and elucidated the mechanisms involved in the changes 
in muscle function. Despite the small sample size, this 
study carries some important clinical messages. First, 
the effectiveness was proportional to current intensity, 
which is clinically relevant when selecting patients for 
NMES. Namely, patients unable to tolerate progression 
of current intensity seem unlikely to beneﬁt from NMES 
when prescribed as a home-based rehabilitation modality. 
Second, between-group differences in exercise capacity 
were not demonstrated. This may relate to a methodological 
issue; that is the authors opted for low exercise intensity 
by stimulating the thigh and calf muscles consecutively 
rather than simultaneously. The systemic effect of NMES, 
as previously shown (Gerovasili et al 2009b), is dependent 
on stimulating adequate muscle bulk, which the authors 
may have better achieved by simultaneously stimulating all 
muscle groups. Finally, the authors assessed the mechanisms 
involved in the improvement of muscle function, which was 
partially attributed to muscle hypertrophy and restoration of 
the anabolic/catabolic balance, although other mechanisms 
such as the role of microcirculation and neural adaptation 
are possible contributors.
NMES is an effective exercise modality for patients with 
severe COPD. Protocol and exercise intensity are relevant to 
induced changes in muscle function, which physiotherapists 
should take into account. Patients intolerant of progression of 
current intensity should be considered for supervised sessions.
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